Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

NCT04380142 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease (PD)

Interventions

DRUG: ABBV-951
DRUG: Placebo for Levodopa/Carbidopa (LD/CD)
DRUG: Levodopa/Carbidopa (LD/CD)
DRUG: Placebo for ABBV-951

Sponsor

AbbVie